Overview
Hiromi Nagashima practices in Japan. Nagashima is rated as an Experienced expert by MediFind in the treatment of Sepsis. Their top areas of expertise are EGFR Positive Lung Cancer, Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Sepsis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerNagashima isAdvanced. Learn about EGFR Positive Lung Cancer.
- Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
- Lung CancerNagashima isAdvanced. Learn about Lung Cancer.
- Experienced
- Acute Interstitial PneumoniaNagashima isExperienced. Learn about Acute Interstitial Pneumonia.
- AsthmaNagashima isExperienced. Learn about Asthma.
- Brain AbscessNagashima isExperienced. Learn about Brain Abscess.
- DiarrheaNagashima isExperienced. Learn about Diarrhea.
- Interstitial Lung DiseaseNagashima isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaNagashima isExperienced. Learn about Lung Adenocarcinoma.